| Thyroid dysfunctions secondary to cancer immunotherapy P Chalan, G Di Dalmazi, F Pani, A De Remigis, A Corsello, P Caturegli Journal of endocrinological investigation 41, 625-638, 2018 | 100 | 2018 |
| Thyroid autoimmunity and thyroid cancer: review focused on cytological studies F Boi, F Pani, S Mariotti European thyroid journal 6 (4), 178-186, 2017 | 83 | 2017 |
| Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features E Pardi, S Borsari, F Saponaro, F Bogazzi, C Urbani, S Mariotti, F Pigliaru, ... PloS one 12 (10), e0186485, 2017 | 56 | 2017 |
| Thyroid dysfunction in patients with metastatic carcinoma treated with sunitinib: is thyroid autoimmunity involved? F Pani, F Atzori, G Baghino, F Boi, L Tanca, MT Ionta, S Mariotti Thyroid 25 (11), 1255-1261, 2015 | 50 | 2015 |
| Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with … R Uras, M Orrù, F Pani, MF Marotto, M Pilloni, S Guerriero, R Etzi, ... Contraception 82 (2), 131-138, 2010 | 41 | 2010 |
| Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer R Elisei, L Lorusso, P Piaggi, L Torregrossa, G Pellegrini, E Molinaro, ... European Journal of Endocrinology 173 (3), 297-304, 2015 | 40 | 2015 |
| Safety and quality-of-life data from an Italian expanded access program of lenvatinib for treatment of thyroid cancer C Giani, L Valerio, A Bongiovanni, C Durante, G Grani, T Ibrahim, ... Thyroid 31 (2), 224-232, 2021 | 38 | 2021 |
| High prevalence of papillary thyroid carcinoma in nodular Hashimoto’s thyroiditis at the first diagnosis and during the follow-up F Boi, F Pani, PG Calo, ML Lai, S Mariotti Journal of Endocrinological Investigation 41, 395-402, 2018 | 30 | 2018 |
| Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis R Giampieri, M Prete, T Prochilo, M Puzzoni, V Pusceddu, F Pani, ... Scientific Reports 7 (1), 45703, 2017 | 24 | 2017 |
| B cells modulate the expression of MHC-II on cardiac CCR2− macrophages C Rocha-Resende, F Pani, L Adamo Journal of molecular and cellular cardiology 157, 98-103, 2021 | 22 | 2021 |
| Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? F Pani, M Massidda, V Pusceddu, M Puzzoni, E Massa, C Madeddu, ... European Journal of Endocrinology 177 (1), 85-92, 2017 | 22 | 2017 |
| The immune landscape of papillary thyroid cancer in the context of autoimmune thyroiditis F Pani, P Caria, Y Yasuda, M Makoto, S Mariotti, L Leenhardt, ... Cancers 14 (17), 4287, 2022 | 20 | 2022 |
| Characterizing the three‐dimensional organization of telomeres in papillary thyroid carcinoma cells P Caria, T Dettori, DV Frau, D Lichtenzstejn, F Pani, R Vanni, S Mai Journal of Cellular Physiology 234 (4), 5175-5185, 2019 | 20 | 2019 |
| The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a … L Orgiano, F Pani, G Astara, C Madeddu, S Marini, A Manca, G Mantovani Supportive Care in Cancer 24, 4293-4299, 2016 | 17 | 2016 |
| Prognostic value of thyroid hormone ratios in patients with advanced metastatic colorectal cancer treated with regorafenib: the TOREADOR study M Schirripa, G Pasqualetti, R Giampieri, M Scartozzi, S Lonardi, ... Clinical colorectal cancer 17 (3), e601-e615, 2018 | 16 | 2018 |
| Pre-existing thyroiditis ameliorates papillary thyroid cancer: insights from a new mouse model F Pani, Y Yasuda, G Di Dalmazi, P Chalan, K Gabrielson, L Adamo, ... Endocrinology 162 (10), bqab144, 2021 | 14 | 2021 |
| Distinct cytokine signatures in thyroiditis induced by PD-1 or CTLA-4 blockade: insights from a new mouse model S Ippolito, G Di Dalmazi, F Pani, E Sabini, P Caturegli Thyroid 31 (12), 1839-1849, 2021 | 13 | 2021 |
| Walter E. Dandy: his contributions to pituitary surgery in the context of the overall Johns Hopkins Hospital experience A Corsello, G Di Dalmazi, F Pani, P Chalan, R Salvatori, P Caturegli Pituitary 20, 683-691, 2017 | 12 | 2017 |
| Thyrospheres from B-CPAP cell line with BRAF and TERT promoter mutations have different functional and molecular features than parental cells P Caria, R Pillai, T Dettori, DV Frau, P Zavattari, G Riva, G Romano, ... Journal of Cancer 8 (9), 1629, 2017 | 12 | 2017 |
| Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status L Schubert, AM Mbekwe-Yepnang, J Wassermann, Y Braik-Djellas, ... Journal of Endocrinological Investigation 47 (6), 1573-1581, 2024 | 8 | 2024 |
Mario ScartozziUniversity of Cagliari, ItalyVerified email at unica.it
